Kadcyla 160mg Injection

Overview Kadcyla 160mg Injection

Trastuzumab emtansine 160mg injection treats both early and advanced breast cancer. Specifically, it targets HER2-positive breast cancer that has metastasized and proven resistant to prior therapies. Administration is exclusively by a healthcare professional via injection; dosage and frequency are determined by your physician based on your individual needs and may vary. Strict adherence to your doctor's prescribed regimen is crucial, as incorrect usage or overdose may lead to severe adverse reactions. While benefits might not be immediately apparent (requiring weeks or months), discontinuation should only occur under medical supervision. Common side effects include fatigue, nausea, musculoskeletal pain, and hemorrhage. This medication can suppress blood cell production, increasing infection risk; therefore, regular blood tests monitoring blood cell counts, along with cardiac, hepatic, and uric acid levels, are necessary. Prior to treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent medications, particularly antifungals or antibiotics. Drug interactions are possible; disclose all medications to your healthcare provider. Use during pregnancy or breastfeeding is contraindicated; effective contraception for both partners is essential throughout treatment. A patient support program, facilitated by Tata 1mg, is accessible in India. Contact your physician or call (1800-102-1618) for further information.

Primary Ingredients of Kadcyla 160mg Injection

No information provided. Please provide the text you wish to be rephrased.

Uses of Kadcyla 160mg Injection

Breast cancer (early stages) | Advanced breast cancer

Major Benefits of Kadcyla 160mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Kadcyla 160mg Injection:

• Tiredness
• Nausea
• Musculoskeletal (bone, muscle or joint) pain
• Bleeding
• Low blood platelets
• Headache
• Liver disorder
• Constipation
• Nosebleeds

How to use Kadcyla 160mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Kadcyla 160mg Injection works:

Trastuzumab emtansine 160mg injection is a targeted anti-neoplastic agent. By attaching to HER2 receptors on breast cancer cells, it marks them for immune system-mediated elimination. Furthermore, the drug's intracellular delivery of emtansine inhibits cancerous cell growth and proliferation.

What if you forget to take Kadcyla 160mg Injection :

Should you omit a scheduled dose of Kadcyla 160mg Injection, seek advice from your physician.